COBRA: Cancer, Older Adults, Balance and Resistance Activities
Interventionsstudie
Phase nicht angegeben
Memorial Sloan Kettering Monmouth (Consent only)
The purpose of this study is to find out whether an 8-week digital health promotion program called COBRA is a safe and practical (feasible) option for older adults with cancer/OAC.
Behandlungskategorie
Verhalten
Erforderliche Mutationen
Keine
Studie gestartet
2025-05-30
Zuletzt vom Sponsor aktualisiert
2025-06-10
Voraussichtlicher Abschluss
2027-05-30
Eignung
Einschlusskriterien
Older Adult Patients with Cancer
- Are within 1 year of completion of primary therapy for cancer OR have a diagnosis of metastatic cancer;
1. For the purpose of this study, primary therapy is defined as treatment of curative intent, first-line or later, from which the individual is advancing to active surveillance or follow-up with or without maintenance therapy.
2. Individuals with metastatic cancer may be included provided they have stable disease or better per most recent restaging exam at time of enrollment.
i. Patients with stable metastatic bony disease at most recent restaging exam and a score of 0-2 on the Functional Pain Scale (FPS69; Appendix 18) are eligible. The PI will consult with the Rehab Med co-PI for FPS scores of 3 or greater, by patient request or PI discretion.
ii. Patients with symptomatic visceral metastases will be evaluated on a case-by-case basis at time of enrollment.
* Are aged 65 years and older, with no upper age limit;
* ECOG PS 0-3 or Karnofsky PS greater than or equal to 40;
* Can read and speak English;
* Self-report access to internet connection sufficient to support videoconferencing.
Clinicians
* Licensed clinician (MD, RN, APP) with an interest in the care of older adults with cancer.
Ausschlusskriterien
Older Adult Patients with Cancer
* Have any cognitive impairment, neurologic, musculoskeletal, or other comorbid condition (as assessed by their provider) that would prevent the individual from engaging with the digital health coaching program or complete study assessments or engage in progressive intensity levels of physical activity
* Have a neurologic, musculoskeletal, or other comorbid condition that would impede their ability to safely engage in progressive intensity levels of physical activity (as assessed by their provider). Patients with metastatic disease and suspected interim progression since last restaging exam will be referred back to their primary oncology care team for evaluation prior to enrollment.
* Have activity restrictions post-surgery at the time of enrollment
Glauben Sie, dass diese klinische Studie fälschlicherweise angezeigt wird?
Design-Details
ZuteilungN/A
InterventionsmodellSingle Group Assignment
MaskierungNone (Open Label)
Anzahl der Teilnehmer38
Arme & Interventionen
Arme
Interventionen
Typ: Experimental
Beschreibung: Older Adult Patients with Cancer are within 1 year of completion of primary therapy for cancer OR have a diagnosis of metastatic cancer;
Interventionen:
Cancer, Older adults, Balance and Resistance Activities
Ergebnismessungen
Primäre Ergebnismessungen
Rate of retention and adherence to the COBRA/Cancer, Older Adults, Balance and Resistance Activities intervention8 weeks
Rate of retention and adherence to the 8-week intervention to define intervention feasibility
Sekundäre Ergebnismessungen
Keine
Interessiert an einer Teilnahme?
Erfahren Sie mehr über diese Studie und ob Sie für eine Teilnahme in Frage kommen.
Studie vormerken
Studie per E-Mail teilen
Studie herunterladen
Glauben Sie, dass diese klinische Studie fälschlicherweise angezeigt wird?
Studie melden
Studie herunterladen
Studienzentren
Diese Studie hat 6 Studienzentren
Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, US
Rekrutierend
Middletown, New Jersey, 07748 US
Memorial Sloan Kettering Monmouth (Consent only)
Rekrutierend
Harrison, New York, 10604 US
Memorial Sloan Kettering Westchester (Consent only)
Rekrutierend
Montvale, New Jersey, 07645 US
Memorial Sloan Kettering Bergen (Consent Only)
Rekrutierend
Uniondale, New York, 11553 US
Memorial Sloan Kettering Nassau (Consent Only)
Rekrutierend
New York, New York, 10065 US
Memorial Sloan Kettering Cancer Center (All Protocol Activites)
Rekrutierend
Commack, New York, 11725 US
Memorial Sloan Kettering Suffolk-Commack (Consent Only)